Results 131 to 140 of about 36,325 (253)

Surgical Outcomes of Sequential Robot‐Assisted Hepatobiliary–Pancreatic Surgery in a Single Operating Room: A Single‐Center Retrospective Analysis of a High‐Volume Center in Japan (TAKUMI‐6)

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1289-1297, July 2026.
This study investigated the surgical outcomes of sequential robot‐assisted hepatobiliary–pancreatic (HBP) in a single operating room. The outcomes and operating room timelines were comparable between the first and second cases. The median turnover time was 49 min, and the day‐shift completion success rate was 34.4%.
Tomokazu Fuji   +7 more
wiley   +1 more source

Epidural Anesthesia

open access: yesVeterinary Clinics of North America: Small Animal Practice, 1992
openaire   +1 more source

Epidural Anesthesia [PDF]

open access: yesJournal of Perinatology, 2004
openaire   +1 more source

Severe Postpartum Hemorrhage After Vaginal Delivery in an Osteogenesis Imperfecta Type I Patient: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Pregnant patients with osteogenesis imperfecta type I are at increased risk of obstetric and hemorrhagic complications. Early multidisciplinary planning and anesthesiology involvement are essential. Severe postpartum hemorrhage may result from uterine atony and tissue fragility, requiring prompt uterotonic therapy, surgical intervention, blood
Madeline Dow   +2 more
wiley   +1 more source

Cryoanalgesia for pain management after open thoracotomy: a reply

open access: yes
Anaesthesia, Volume 81, Issue 8, Page 1172-1172, August 2026.
Marie‐Pierre Bonnet
wiley   +1 more source

Targeted senotherapy improves electrographic and behavioral outcomes in a mouse model of temporal lobe epilepsy

open access: yesEpilepsia, Volume 67, Issue 7, Page 3779-3790, July 2026.
Abstract Objective Current pharmacotherapy for temporal lobe epilepsy (TLE) is limited to symptomatic treatment and leaves approximately one third of patients with inadequate seizure control. Discovering disease‐modifying targets is an unmet clinical need. We have previously identified senescent cells (SCs) as one such target. Many drugs that eliminate
David J. McFall   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy